参考文献/References:
[1] Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol, 2004, 71(2):201-206.
[2] Liang SB, Sun Y, Liu LZ, et al.Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging:improvement of clinical target volume delineation. Int J Radiat Oncol Biol Phys, 2009, 75(3):742-750.
[3] Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT):biological Imaging and biological conformality. Int J Radiat Oncol Biolphys, 2000, 47(3):551-560.
[4] 何侠,朱向帜,黄德健,等.磁共振弥散加权成像和PET/CT在鼻咽癌调强放射治疗中的应用.肿瘤学杂志,2008,14(10):783-786.
[5] Heron DE, Andrade RS, Flickinger J, et al. Hybrid PET/CT simulation for radiation treatment planning in head-and-neck cancers:a brief technical report. Int J Radiat Oncol Biol Phys, 2004, 60(5):1419-1424.
[6] 何侠,朱向帜,翟振宇,等.MR/CT和18FDG PET/CT对鼻咽癌肿瘤区勾画比较研究.齐齐哈尔医学院学报,2007,28(24):2945-2948.
[7] Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy:a pilot investigation. Head Neck, 2005, 27(6):478-487.
[8] Breen SL, Publicover, De-Silva S, et al.Intraobserver and interobserver variability in GTV delineation on FDG-PET/CT images of head and neck cancers. Int J Radiat Oncol Biol Phys, 2007, 68(3):763-770.
[9] Zheng XK, Chen LH, Wang QS, et al. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally reurcrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2007, 69(5):1381-1388.
[10] Zheng XK, Chen LH, Wang QS, et al. Influence of 18F-fluorodeoxyglncose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma. Int Radiat Oncol Biol Phys, 2006, 65(4):1020-1025.
[11] Murakami R, Uozumi H, Hirai T, et al. Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma:intermethod and interobserver variations. Acta Radiol, 2008, 49(6):693-699.
[12] Guido A, Fuccio L, Rombi B, et al. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2009, 73(3):759-763.
[13] Heron DE, Andrade RS, Flickinger J, et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancer:a brief technical report. Int J Radiat Oncol Biol Phys, 2004, 60(5):1419-1424.
[14] Koshy M, Paulino AC, Howell R, et al. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck, 2005, 27(6):494-502.
[15] Hall EJ, Wuu CS, Radiation-induced second cancers:the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys, 2003, 56(1):83-88.
[16] Skala M, Holloway L, Bailey M, et al, Australia-wide comparison of intensity modulated radiation therapy prostate plans. Australas Radiol, 2005, 49(3):222-229.
[17] Gagne IM, Robinson DM. The impact of tumor motion upon CT image integrity and target delineation. Med Phys, 2004, 31(12):3378-3392.
[18] Yu H, Caldwell C, Mah K, et al. Automated radiation rargeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys, 2009, 75(2):618-625.
[19] Steenbakkers R J, Duppen JC, Fitton I. Reduction of observer varition using matched CT-PET for lung cancer delineation:A three-dimensional analysis. Int J Radiat Oncol Biol Phys, 2006, 64(2):435-448.
[20] Vesprini D, Ung Y, Kamra J, et al. The addition of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) to CT based radiotherapy planning of carcinoma of the esophagus decreases both the intra-and-inter observer variability of GTV delineation. Int J Radiat Oncol Biol Phys, 2006, 66(Suppl 3):299-300.
[21] Bentzen SM. Theragnostic imaging for radiation oncology:dosepainting by numbers. Lancet Oncol, 2005, 6(2):112-117.
[22] Bentzen SM. Dose painting and theragnostic imaging:towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res, 2008, 139(1):40-61.
[23] Aerts HJ, van Baardwijk AA, Petit SF, et al. Identification of residual metabolicaetive areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan. Radiother Oncol, 2009, 91(3):386-392.
[24] Abramyuk A, Tokalov S, Zophel K, et al. Is pre-therapeutical FDGPET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?. Radither Oncol, 2009, 91(3):399-404.
[25] Aerts HI, Bosmans G, van Baardwijk AA, et al. Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC:a prospective study. Int J Radiat Oncol Biol Phys, 2008, 71(5):1402-1407.
[26] Schütze C, Bergmann R, Yaromina A, et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol, 2007, 83(3):311-315.
[27] Duprez F, De Neve W, De Gersem W, et al. Adaptive dose painting by numbers for head-and-neck cancer, Int J Radiat Oncol Biol Phys, 2010, 80(4):1045-1055.
[28] El-Bassiouni M, Ciernik IF, Davis JB, et al.[18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer. Int J Radiat Oncol Biol Phys, 2007, 69(1):286-293.
[29] Kao CH, Hsieh TC, Yu CY, et al.18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer:a correlation study between suitable uptake value threshold and tumor parameters. Radiat Oncol, 2010, 5:76.
[30] Moule RN, Kayani L, Moinuddin SA, et al. The potential advantages of (18F)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer. Radiother Oncol, 2010, 97(2):189-193.
[31] 肖建平,徐国镇.立体定向放射治疗:提高鼻咽癌局部控制的有效方法.癌症, 201029(2):129-131.
[32] 林少俊,潘建基,吴君心等.鼻咽癌外照射加腔内近距离超分割推量照射的远期疗效分析.癌症,2007,26(2):208-211.
[33] 潘纯国,吴少雄,赵充,等.鼻咽癌常规放射治疗后颅底推量的临床价值评估.肿瘤学杂志,2010(8):648-652.
[34] Porceddu SV, Jarmolowski E, Hicks R, et al. Utility of positron emission tomography for the detection disease in residual neck nodes later (chemo) radiotherapy in head and neck cancer. Head Neck, 2005, 27(3):175-181.
[35] Peng N, Yen S, Liu W, et al. Evaluation of the effect of radiation therapy to nasopharyngeal carcinoma by positron emission tomography with 2-F-18Fluoro-2-deoxy-D-glueose. Clin Positron Imaging, 2000, 3(2):51-56.
[36] Yen TC, Chang JT, Ng SH, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med, 2005, 46(3):405-410.
[37] Mohhoff CF, Klabers BM, Berkhof I, et al. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice comparison of 2-deoxy-2[18F]fluoro-D-glucose (FDG)and 3-(18F) fluoro-3-deoxythymidine (FLT). Mol Imaging Biol, 2007, 9(6):340-347.
[38] 袁建伟,冯彦林,冼伟均,等.利用18F-FDGPET-CT显像监测裸鼠鼻咽癌移植瘤早期放疗疗效的研究.癌症,2010,29(4):409-414.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[11]冯彦林,王颖,张宁,等.鼻咽癌不同模式放疗后的PET/CT早期评估价值的研究[J].国际放射医学核医学杂志,2014,38(4):223.[doi:10.3760/cma.j.issn.1673-4114.2014.04.004]
Feng Yanlin,Wang Ying,Zhang Ning,et al.Early evaluation value of PET/CT in nasopharyngeal carcinoma after different models of radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):223.[doi:10.3760/cma.j.issn.1673-4114.2014.04.004]
[12]陈凤华,李东坡,郭萍,等.整体护理对鼻咽癌患者放疗期间口腔黏膜损伤防治的作用[J].国际放射医学核医学杂志,2012,36(3):176.[doi:10.3760/cma.j.issn.1673-4114.2012.03.014]
CHEN Feng-hua,LI Dong-po,GUO Ping,et al.Effects of holistic nursing on protection and control of nasopharyngeal carcinomapatient’ oral mucosa damage during radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):176.[doi:10.3760/cma.j.issn.1673-4114.2012.03.014]
[13]邱新峰,刘强.鼻咽癌放疗致放射性脑损伤的临床分析[J].国际放射医学核医学杂志,2008,32(3):191.
[14]何小江,黄劲雄,俞浩,等.腮腺动态显像评价鼻咽癌放疗对腮腺功能的影响[J].国际放射医学核医学杂志,2008,32(5):272.
HE Xiao-jiang,HUANG Jin-xiong,YU Hao,et al.Evaluation of parotid function using dynamic parotid scintigraphy in nasopharyngeal carcinoma patients treated with external beam radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):272.
[15]苏新辉,吴华,黄劲雄,等.99mTc-HL91乏氧显像评价30例鼻咽癌患者放疗疗效[J].国际放射医学核医学杂志,2008,32(2):99.
SU Xin-hui,WU Hua,HUANG Jing-xiong,et al.The application of 99mTc-HL91 hypoxic imaging in detecting radiotherapy response in 30 patients with nasopharyngeal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):99.
[16]鲁杰,刘强.老年鼻咽癌115例放疗疗效评价[J].国际放射医学核医学杂志,2008,32(4):254.
[17]薛咏,刘生,张弘,等.鼻咽癌乏氧程度与放疗中期肿瘤退缩关系的初步研究[J].国际放射医学核医学杂志,2007,31(4):232.
XUE Yong,LIU Sheng,ZHANG Hong,et al.The relationship between tumor regression degree and its hypoxia degree in patients with nasopharyngeal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(2):232.
[18]杨明威,王孝深,王凡,等.顺铂单周与三周方案同期联合调强放射治疗局部晚期鼻咽癌的不良反应与疗效的比较[J].国际放射医学核医学杂志,2018,(5):397.[doi:10.3760/cma.j.issn.1673-4114.2018.05.002]
Yang Mingwei,Wang Xiaoshen,Wang Fan,et al.Comparison of toxicities and treatment outcome of weekly and triweekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):397.[doi:10.3760/cma.j.issn.1673-4114.2018.05.002]